Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wang C et al. – The expression of VEGF in HCC tissues and HBV BCP mutations were found to be independent prognostic factors for recurrence–free survival. Strong expression of VEGF in HCC tissues and HBV BCP mutations are important risk predictors for recurrence or metastasis of HCC smaller than 5 cm in diameter.


Today in Hepatobiliary/Pancreas...keeping you current

Surgical management of hepatocellular carcinoma: Is the jury still out
Surgical Oncology, 11/05/09

Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials
British Journal of Cancer, 11/13/09

Macronutrients, fatty acids, cholesterol and pancreatic cancer
European Journal of Cancer, 10/27/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address